from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3578/arsB2

LFCtreatmentdescriptionclass of inhibitor

-1.516

Amikacinug/mL Amikacintranslation

-0.674

Cap5-10ug/mL Capreomycintranslation

-0.854

Rox10-50 ug/mL Roxithromycintranslation

-0.877

SM2-5 ug/mL Streptomycintranslation

-1.349

Tet5-10 ug/mL Tetracyclinetranslation

-0.508

Rif0.2-5ug/mL Rifampicintranscription

-1.753

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.189

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.641

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.159

CPZ10-50 ug/mL Chlorpromazinerespiration

0.703

Clofazimine10-13 ug/mL Clofaziminerespiration

0.203

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.071

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.333

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.741

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.371

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.233

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.109

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.303

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.245

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.089

KCN5-20 ug/mL Potassium cyaniderespiration

0.166

NaN30.2-2 mM Sodium aziderespiration

-0.706

Nigericin50 uM Nigericinrespiration

0.460

TRC10-150 ug/mL Triclosanrespiration

0.944

TRZ10-25 ug/mL Thioridazinerespiration

-1.035

Valinomycin0.5-10 uM Valinomycinrespiration

-1.879

ZnSO42 mM ZnSO4respiration

-0.332

menadione6-10 ug/mL Menadionerespiration

0.295

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.462

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.499

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.681

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.097

NRP_1Non-replicating persistence stage 1dosRassociated

-0.305

Amp0.2mg/mL AmpicillincellWall

-0.257

Cephalexin20-100 ug/mL CephalexincellWall

-0.226

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.702

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.383

EMB10-20 ug/mL EthambutolcellWall

-0.682

Eta12-40 ug/mL EthionamidecellWall

-0.437

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.398

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.912

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.044

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.156

BZA0.12 mg/mL BenzamidearomaticAmides

0.228

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.094

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.975

H2O24 mM hydrogen peroxideDNAdamaging

-0.388

Levo10 ug/mL LevofloxacinDNAdamaging

0.448

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.739

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.835

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.446

UVUV-irradiationDNAdamaging

0.955

ARP41-4 ug/mL Antitubercular compound ARP4?

0.603

Antimycin12.5-50 ug/mL Antimycin A?

0.548

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.568

PA_110-50 ug/mL Antitubercular compound PA-1?

0.325

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.091

PA8240.2-2 ug/mL PA-824?

0.599

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.411

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.556

Verapamil50 uM Verapamil?

-0.623

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.371

methoxatin10-20 ug/mL Methoxatin?